SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Michigan Biologic Products, Inc. (Last) (First) (Middle) 5723 DELTA RIVER DRIVE (Street) LANSING MI 48906 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Emergent BioSolutions Inc. [ EBS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner Officer (give title below) X Other (specify below) Member 13(d) group owning >10%
	3. Date of Earliest Transaction (Month/Day/Year) 09/06/2007
	4. If Amendment, Date of Original Filed (Month/Day/Year) 09/10/2007	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/06/2007		S(1)		1,100	D	$8.55	1,910,650(2)	D
Common Stock	09/06/2007		S(1)		415	D	$8.6	1,910,235(2)	D
Common Stock	09/06/2007		S(1)		300	D	$8.61	1,909,935(2)	D
Common Stock	09/06/2007		S(1)		400	D	$8.62	1,909,535(2)	D
Common Stock	09/06/2007		S(1)		1,600	D	$8.63	1,907,935(2)	D
Common Stock	09/06/2007		S(1)		300	D	$8.64	1,907,635(2)	D
Common Stock	09/06/2007		S(1)		100	D	$8.65	1,907,535(2)	D
Common Stock	09/06/2007		S(1)		100	D	$8.66	1,907,435(2)	D
Common Stock	09/06/2007		S(1)		900	D	$8.67	1,906,535(2)	D
Common Stock	09/06/2007		S(1)		200	D	$8.68	1,906,335(2)	D
Common Stock	09/06/2007		S(1)		200	D	$8.7	1,906,135(2)	D
Common Stock	09/06/2007		S(1)		800	D	$8.71	1,905,335(2)	D
Common Stock	09/06/2007		S(1)		100	D	$8.72	1,905,235(2)	D
Common Stock	09/06/2007		S(1)		500	D	$8.73	1,904,735(2)	D
Common Stock	09/06/2007		S(1)		200	D	$8.75	1,904,535(2)	D
Common Stock	09/06/2007		S(1)		100	D	$8.76	1,904,435(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2007.

2. A Form 4 filed by the Reporting Person on September 6, 2007 incorrectly stated the amount of common stock sold on September 4, 2007 by the Reporting Person. An amendment to that Form 4 has been filed with the SEC to report the correct number of common stock sold (a lower number) and, correspondingly, corrects the number of common stock beneficially owned by the Reporting Person after such sales. Since the Reporting Person sold less common stock on September 4, 2007 than initially reported on its Form 4 on September 6, 2007, after the correction, there is a correlative increase in the reported number of common stock beneficially owned by the Reporting Person. Accordingly, this Amendment corrects the number of common stock reported as beneficially owned by the Reporting Person after the sale transactions executed on September 6, 2007 and reported on September 10, 2007.

	/s/ Carl A. Valenstein, attorney in fact	09/14/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.